Extractables & Leachables Symposium for Drugs & Devices
Join a select group of industry colleagues for a complimentary full day seminar focused on extractables and leachables testing for drug products and medical devices, including:
- Insights on current and upcoming regulations directly from a USP representative.
- Case studies from the industry’s leading bio/pharmaceutical and medical device companies.
- Best practices and strategies for establishing an extractables study design and biocompatibility testing from experienced scientists.
- A tour of Eurofins' 330,000 square-foot state-of-the-art testing facility.
If you are a director or manager in a medical device or bio/pharmaceutical company responsible for analytical chemistry/research and development, manufacturing/process development, quality control or procurement and sourcing, you don’t want to miss this event.
Date: October 12, 2017
Time: 8:00 a.m. - 5:30 p.m.
Dinner event to follow at 6:00 p.m.
Location: Eurofins' Lancaster, PA Campus
2430 New Holland Pike
Lancaster, PA 17601
View our past seminars
Changes in Europe's Medical Device Regulations: Consequences for Manufacturers
Peter Diesing, Ph.D. Head of Certification, Eurofins Medical Device Testing
Developing Test Strategies Per the New ISO 10993-1: Current Status & Upcoming Changes
Hana Hofman-Huether, Ph.D., Head of Consulting, Toxicology, Eurofins Medical Device Testing
Chemical Characterization: The Starting Point for Biological Evaluations
Hannah S. Tims, Ph.D., Senior Chemist, Eurofins Medical Device Testing
Biocompatibility Basics: Making Sense of the Annex A Matrix
Odete Mendes, Ph.D., Director of Toxicology & Pathology,Eurofins Medical Device Testing
Developing a Testing Plan for Medical Device Design Verification
Stephen Spiegelberg, Ph.D., President,Cambridge Polymer Group, Inc.
Endotoxin Testing: Make Sure FDA's New Guidance Doesn't Delay Your Product Launch
Tami Benjamin,Director, Microbiology, Eurofins Medical Device Testing